Therapeutic potential of IL-15 in rheumatoid arthritis

Hum Immunol. 2015 Nov;76(11):812-8. doi: 10.1016/j.humimm.2015.09.041. Epub 2015 Sep 30.

Abstract

Rheumatoid arthritis (RA) is a chronic, destructive inflammatory autoimmune disease. Cytokine-mediated immunity has been found to play an important role in the pathogenesis of autoimmune diseases including RA. Recently, much attention has been paid on the role of IL-15, which is a member of the 4 α-helix bundle cytokine family. IL-15 was detected in serum and synovial fluid from RA patients and arthritis mice models. Moreover, administration of IL-15 leads to the development of severe inflammatory arthritis, suggesting that IL-15 may be therapeutically relevant in RA. Therefore, targeting IL-15 may be significantly important and valuable. In this article, we discuss the biological features and effects of IL-15 and summarize recent advances on the pathological roles of IL-15 in RA and treatment for RA.

Keywords: Autoimmune; Cytokine; Interleukin-15; Rheumatoid arthritis; Therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / etiology*
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Gene Expression Regulation / drug effects
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Interleukin-15 / chemistry
  • Interleukin-15 / pharmacology
  • Interleukin-15 / physiology
  • Interleukin-15 / therapeutic use*
  • Signal Transduction / drug effects

Substances

  • Immunologic Factors
  • Interleukin-15